The store will not work correctly when cookies are disabled.
1-Ethenyl-6,8-difluoro-7-(4-bromo-piperidinyl)-4(1H)-oxoquinoline-3-carboxylic acid
ID: ALA1631377
PubChem CID: 50907734
Max Phase: Preclinical
Molecular Formula: C17H17BrF2N2O3
Molecular Weight: 415.23
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCC(Br)CC3)c(F)c21
Standard InChI: InChI=1S/C17H17BrF2N2O3/c1-2-21-8-11(17(24)25)16(23)10-7-12(19)15(13(20)14(10)21)22-5-3-9(18)4-6-22/h7-9H,2-6H2,1H3,(H,24,25)
Standard InChI Key: WHDQXUQCKNTJJP-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
5.9440 -23.5775 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9428 -24.4048 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6576 -24.8177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6558 -23.1648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3711 -23.5739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3719 -24.4006 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0871 -24.8116 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.8021 -24.3968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7974 -23.5670 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0815 -23.1597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2294 -23.1652 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
5.2280 -24.8167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.6595 -25.6426 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
8.0771 -22.3349 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.5092 -23.1501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2262 -23.5583 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.5042 -22.3252 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.0888 -25.6365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8042 -26.0475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5177 -24.3992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8051 -24.8076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8002 -25.6328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5141 -26.0481 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2329 -25.6380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0839 -26.0421 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
2 12 1 0
5 6 1 0
3 13 1 0
3 6 2 0
10 14 2 0
6 7 1 0
9 15 1 0
1 2 2 0
15 16 1 0
7 8 1 0
15 17 2 0
5 4 2 0
7 18 1 0
8 9 2 0
18 19 1 0
12 20 1 0
4 1 1 0
9 10 1 0
10 5 1 0
1 11 1 0
12 24 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
2 3 1 0
22 25 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 415.23 | Molecular Weight (Monoisotopic): 414.0391 | AlogP: 3.36 | #Rotatable Bonds: 3 |
Polar Surface Area: 62.54 | Molecular Species: ACID | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 5.76 | CX Basic pKa: ┄ | CX LogP: 2.98 | CX LogD: 1.33 |
Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.78 | Np Likeness Score: -0.55 |
References
1. Srinivasan S, Beema Shafreen RM, Nithyanand P, Manisankar P, Pandian SK.. (2010) Synthesis and in vitro antimicrobial evaluation of novel fluoroquinolone derivatives., 45 (12): [PMID:20933306] [10.1016/j.ejmech.2010.09.036] |